Initial symptoms of dementia predict speed of progression, study finds
By
Alicia Lasek
Mar 16, 2023
No matter the type of underlying brain changes, the first cognitive symptoms of dementia help predict long-term functional outcomes, researchers report.
Key CDC advisers set to scrutinize evidence for vaccine booster shots
By
Alicia Lasek
Aug 11, 2021
The question of whether a COVID-19 booster shot will be helpful and safe may receive an answer Friday. That is when the CDC’s top vaccine advisers will meet to review updated evidence for recommending...
Use of common sleep meds nosedives, with 86 percent drop in oldest adults
By
Alicia Lasek
Aug 17, 2022
The use of sleep medications among Americans dropped by 31% just prior to the pandemic, with the steepest decline among adults aged 80 and older, investigators report.
CDC: 1 in 5 adults live with chronic pain
By
Alicia Lasek
Apr 16, 2023
An estimated 21% of U.S. adults experienced chronic pain in 2021, and 7% reported chronic pain that restricts their daily activities, according to a new analysis.
Switch to race-neutral equation would affect millions of U.S. kidney patients: study
By
Alicia Lasek
Feb 16, 2022
A highly recommended transition away from race-based measurements of kidney function resulted in new kidney disease classifications for 5.5 million patients in an analysis of 39,000, investigators say.
One in 10 older U.S. adults has dementia, new national data show
By
Alicia Lasek
Oct 25, 2022
Ten percent of U.S. seniors have dementia and another 22% have cognitive impairment, finds the first such national study in two decades.
Multimorbidity may up seniors’ dementia risk by 63 percent over 15 years
By
Alicia Lasek
Oct 03, 2022
Identifying high-risk disease clusters could help clinicians to better target patients for dementia care, researchers say.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.